Chiricozzi, A, Di Nardo, L, Talamonti, M, Galluzzo, M, De Simone, C, Fabbrocini, G, Marzano, AV, Girolomoni, G, Offidani, A, Rossi, MT, Bianchi, L, Cristaudo, A, Fierro, MT, Stingeni, L, Pellacani, G, Argenziano, G, Patrizi, A, Pigatto, P, Romanelli, M
, Savoia, P, Rubegni, P, Foti, C, Milanesi, N, Belloni Fortina, A, Bongiorno, MR, Grieco, T, Di Nuzzo, S, Fargnoli, MC, Carugno, A, Motolese, A, Rongioletti, F, Amerio, P, Balestri, R, Potenza, C, Micali, G, Patruno, C, Zalaudek, I, Lombardo, M, Feliciani, C, Antonelli, F, Ferrucci, SM, Guarneri, F & Peris, K 2022, '
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy',
Dermatitis, vol. 33, no. 3, pp. e25-e29.
https://doi.org/10.1097/DER.0000000000000814